Molecular Oncology

Article	Citations
Targeting immunogenic cell death in cancer	373
Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms	196
Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A	110
LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma	110
DNA in extracellular vesicles: biological and clinical aspects	95
Clinical utility of circulating tumor cells: an update	94
The effect of surgical trauma on circulating free DNA levels in cancer patients—implications for studies of circulating tumor DNA	86
Clearance of therapy‐induced senescent tumor cells by the senolytic ABT‐263 via interference with BCL‐XL–BAX interaction	86
Radiotherapy–immunotherapy combinations – perspectives and challenges	84
Exosome‐transmitted circ_MMP2 promotes hepatocellular carcinoma metastasis by upregulating MMP2	77
Prevention and treatment of radiotherapy‐induced side effects	75
Cellular senescence in cancer: from mechanisms to detection	73
Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival	71
Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS–mitochondrial fission–mitophagy axis	70
A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment	65
Clinical significance of clonal hematopoiesis in the interpretation of blood liquid biopsy	59
Identification and validation of a combined hypoxia and immune index for triple‐negative breast cancer	58
Long noncoding RNA SLC2A1‐AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway	58
Image guidance in radiation therapy for better cure of cancer	57
iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation	56
CircFNDC3B sequestrates miR‐937‐5p to derepress TIMP3 and inhibit colorectal cancer progression	55
Global mapping of cancers: The Cancer Genome Atlas and beyond	53
Autophagy, the innate immune response and cancer	53
Technology‐driven research for radiotherapy innovation	53
AAV‐mediated gene transfer of DNase I in the liver of mice with colorectal cancer reduces liver metastasis and restores local innate and adaptive immune response	50

Particle therapy in Europe	49
Overcoming the senescence‐associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer	49
LncRNA NKX2‐1‐AS1 promotes tumor progression and angiogenesis via upregulation of SERPINE1 expression and activation of the VEGFR‐2 signaling pathway in gastric cancer	48
Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer	47
Provision and use of radiotherapy in Europe	45
Dual inhibition of TGF‐β and PD‐L1: a novel approach to cancer treatment	45
LncRNA AATBC regulates Pinin to promote metastasis in nasopharyngeal carcinoma	44
METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5	44
Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution	44
Immune response drives outcomes in prostate cancer: implications for immunotherapy	44
FOXD1‐AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway	43
Serum small extracellular vesicle‐derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma	43
Cancer diagnostics based on plasma protein biomarkers: hard times but great expectations	43
Detection and relevance of epigenetic markers on ctDNA: recent advances and future outlook	42
Doxorubicin‐induced senescence promotes stemness and tumorigenicity in EpCAM−/CD133− nonstem cell population in hepatocellular carcinoma cell line, HuH‐7	42
Enhancing cancer‐associated fibroblast fatty acid catabolism within a metabolically challenging tumor microenvironment drives colon cancer peritoneal metastasis	41
Classification of diffuse lower‐grade glioma based on immunological profiling	41
Early assessment of circulating tumor DNA after curative‐intent resection predicts tumor recurrence in early‐stage and locally advanced non‐small‐cell lung cancer	39
Circulating platelets as liquid biopsy sources for cancer detection	38
Variability of EGFR exon 20 insertions in 24 468 Chinese lung cancer patients and their divergent responses to EGFR inhibitors	37
Tobacco control policies in the 21st century: achievements and open challenges	37
Mast cell‐based molecular subtypes and signature associated with clinical outcome in early‐stage lung adenocarcinoma	34
Linc‐ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR‐194‐3p targeting MECP2	34
Retracted: Exosomal miR‐1255b‐5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial‐to‐mesenchymal transition	33
Circulating tumor cell profiling for precision oncology	33
TGFBI modulates tumour hypoxia and promotes breast cancer metastasis	32
A novel prognostic mRNA/miRNA signature for esophageal cancer and its immune landscape in cancer progression	32
Metabolomic profile of cancer stem cell‐derived exosomes from patients with malignant melanoma	31
Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR‐140‐3p/SKA2 axis	31
Combination therapy with androgen receptor N‐terminal domain antagonist EPI‐7170 and enzalutamide yields synergistic activity in AR‐V7‐positive prostate cancer	31
Cellular senescence and the tumour microenvironment	31
Estrogen receptor α promotes lung cancer cell invasion via increase of and cross‐talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways	30
Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2	30
Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy	30
Fragment‐based drug discovery—the importance of high‐quality molecule libraries	30
Human fibronectin extra domain B as a biomarker for targeted therapy in cancer	29
Towards a cancer mission in Horizon Europe: recommendations	29
Circulating exosomal miR‐363‐5p inhibits lymph node metastasis by downregulating PDGFB and serves as a potential noninvasive biomarker for breast cancer	29
Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma	29
Extracellular vesicles and oncogenic signaling	29
The FABP12/PPARγ pathway promotes metastatic transformation by inducing epithelial‐to‐mesenchymal transition and lipid‐derived energy production in prostate cancer cells	29
CircRNA EPHB4 modulates stem properties and proliferation of gliomas via sponging miR‐637 and up‐regulating SOX10	28
Darolutamide antagonizes androgen signaling by blocking enhancer and super‐enhancer activation	28
Periostin+cancer‐associated fibroblasts promote lymph node metastasis by impairing the lymphatic endothelial barriers in cervical squamous cell carcinoma	28
LncRNA SOX2‐OT regulates AKT/ERK and SOX2/GLI‐1 expression, hinders therapy, and worsens clinical prognosis in malignant lung diseases	28
FOXM1D potentiates PKM2‐mediated tumor glycolysis and angiogenesis	28
Circular RNA profiling identifies circ102049 as a key regulator of colorectal liver metastasis	28
Multifaceted activities of transcription factor EB in cancer onset and progression	28
A novel cell‐free DNA methylation‐based model improves the early detection of colorectal cancer	28
Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA	27

SMARCA4 mutations in KRAS‐mutant lung adenocarcinoma: a multi‐cohort analysis	27
Long noncoding RNA SNHG12 induces proliferation, migration, epithelial–mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post‐transcriptional regulation of BMI1 and	27
Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients	27
Vitamin D supplementation to the older adult population in Germany has the cost‐saving potential of preventing almost 30 000 cancer deaths per year	27
SENP3 loss promotes M2 macrophage polarization and breast cancer progression	27
Long noncoding RNA DANCR confers cytarabine resistance in acute myeloid leukemia by activating autophagy via the miR‐874‐3P/ATG16L1 axis	27
Resistance to DNA repair inhibitors in cancer	27
Pericyte‐secreted IGF2 promotes breast cancer brain metastasis formation	26
Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges	26
Retracted: Long non‐coding RNA PGM5‐AS1 promotes epithelial‐mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR‐140‐5p‐mediated FBN1 inhibition	26
The DNA methylation landscape of hematological malignancies: an update	26
HPV‐related methylation‐based reclassification and risk stratification of cervical cancer	26
LAMC1 upregulation via TGFβ induces inflammatory cancer‐associated fibroblasts in esophageal squamous cell carcinoma via NF‐κB–CXCL1–STAT3	26
EHMT1 knockdown induces apoptosis and cell cycle arrest in lung cancer cells by increasing CDKN1A expression	26
Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis	26
Autophagy activation and SREBP‐1 induction contribute to fatty acid metabolic reprogramming by leptin in breast cancer cells	25
Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non‐small cell lung cancer	25
Characterization of super‐enhancer‐associated functional lncRNAs acting as ceRNAs in ESCC	25
Advances in optical gastrointestinal endoscopy: a technical review	25
Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma	24
Targeted inhibition of STAT3 induces immunogenic cell death of hepatocellular carcinoma cells via glycolysis	24
Long noncoding RNA LINC01578 drives colon cancer metastasis through a positive feedback loop with the NF‐κB/YY1 axis	24
Targeting KRAS mutant lung cancer: light at the end of the tunnel	23
Autophagy at the intersection of aging, senescence, and cancer	23
Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer	23
SST gene hypermethylation acts as a pan‐cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood‐based diagnosis	23
The STAT3‐miR‐223‐TGFBR3/HMGCS1 axis modulates the progression of cervical carcinoma	23
RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K‐RAS mutant tumors	23
Rho‐associated protein kinase‐dependent moesin phosphorylation is required for PD‐L1 stabilization in breast cancer	23
Cancer‐associated fibroblast migration in non‐small cell lung cancers is modulated by increased integrin α11 expression	23
Fluid shear stress activates YAP to promote epithelial–mesenchymal transition in hepatocellular carcinoma	23
Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancer	23
Deubiquitinase OTUD6A promotes proliferation of cancer cells via regulating Drp1 stability and mitochondrial fission	22
Molecular and clinicopathological characteristics of ROS1‐rearranged non‐small‐cell lung cancers identified by next‐generation sequencing	22
Pathological validation and prognostic potential of quantitative MRI in the characterization of pancreas cancer: preliminary experience	22
Autophagy inhibits cancer stemness in triple‐negative breast cancer via miR‐181a‐mediated regulation of ATG5 and/or ATG2B	22
The evolutionarily conserved long non‐coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms	22
Allele‐specific proximal promoter hypomethylation of the telomerase reverse transcriptase gene (TERT) associates with TERT expression in multiple cancers	22
What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyond	22
Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle‐derived long noncoding RNAs identified as markers	22
TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status	22
Gene expression profiles of breast cancer metastasis according to organ site	22
Single‐cell transcriptomics reveal the intratumoral landscape of infiltrated T‐cell subpopulations in oral squamous cell carcinoma	22
Lipidomic profiling of exosomes from colorectal cancer cells and patients reveals potential biomarkers	22
Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer	22
Prevalence of PRKDC mutations and association with response to immune checkpoint inhibitors in solid tumors	21
Cancer‐associated fibroblasts educate normal fibroblasts to facilitate cancer cell spreading and T‐cell suppression	21
Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity	21
FUBP1 promotes colorectal cancer stemness and metastasis via DVL1‐mediated activation of Wnt/β‐catenin signaling	21
Long non‐coding RNA RACGAP1P promotes breast cancer invasion and metastasis via miR‐345‐5p/RACGAP1‐mediated mitochondrial fission	21
Protein palmitoylation in cancer: molecular functions and therapeutic potential	21
Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study	21
Aspirin sensitizes osimertinib‐resistant NSCLC cells in vitro and in vivo via Bim‐dependent apoptosis induction	20
The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas	20
Platycodin D inhibits autophagy and increases glioblastoma cell death via LDLR upregulation	20
Occupational cancer burden: the contribution of exposure to process‐generated substances at the workplace	20
Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors	20
A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis	20
Epithelial/mesenchymal heterogeneity of high‐grade serous ovarian carcinoma samples correlates with miRNA let‐7 levels and predicts tumor growth and metastasis	20
Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment	20
A thiopyrylium salt for PET/NIR‐II tumor imaging and image‐guided surgery	20
Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer	20
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer	20
Downregulation of adipose triglyceride lipase by EB viral‐encoded LMP2A links lipid accumulation to increased migration in nasopharyngeal carcinoma	20
Somatic mutations and copy number variations in breast cancers with heterogeneous HER2 amplification	19
Serum markers improve current prediction of metastasis development in early‐stage melanoma patients: a machine learning‐based study	19
FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells	19
Phosphorylation of the androgen receptor at Ser81 is co‐sustained by CDK1 and CDK9 and leads to AR‐mediated transactivation in prostate cancer	19
Pre‐analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients	19
Irradiation‐induced polyploid giant cancer cells are involved in tumor cell repopulation via neosis	19
CircATRNL1 activates Smad4 signaling to inhibit angiogenesis and ovarian cancer metastasis via miR‐378	19
MYC and therapy resistance in cancer: risks and opportunities	19
Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment	19
Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients	19
Vaccination against HPV: boosting coverage and tackling misinformation	19
TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancer	19
High‐throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype‐specific serologically relevant biomarkers	19
Viruses in colorectal cancer	19
Platelets are recruited to hepatocellular carcinoma tissues in a CX3CL1‐CX3CR1 dependent manner and induce tumour cell apoptosis	18
TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas	18

E2F1‐activated SPIN1 promotes tumor growth via a MDM2‐p21‐E2F1 feedback loop in gastric cancer	18
PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth	18
The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settings	18
The lncRNA ‘UCA1’ modulates the response to chemotherapy of ovarian cancer through direct binding to miR‐27a‐5p and control of UBE2N levels	18
Identification of BLNK and BTK as mediators of rituximab‐induced programmed cell death by CRISPR screens in GCB‐subtype diffuse large B‐cell lymphoma	18
Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion	18
A novel prognostic model based on four circulating miRNA in diffuse large B‐cell lymphoma: implications for the roles of MDSC and Th17 cells in lymphoma progression	18
Comprehensive cross‐platform comparison of methods for non‐invasive EGFR mutation testing: results of the RING observational trial	18
Intracellular matrix Gla protein promotes tumor progression by activating JAK2/STAT5 signaling in gastric cancer	17
A novel circular RNA, hsa_circ_0030998 suppresses lung cancer tumorigenesis and Taxol resistance by sponging miR‐558	17
Constitutive activation of integrin αvβ3 contributes to anoikis resistance of ovarian cancer cells	17
SIK2 represses AKT/GSK3β/β‐catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases	17
Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen receptor‐positive disease	17
Blood DNA methylation profiles improve breast cancer prediction	17
The ZEB2‐dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer	17
Integrative analysis of gut microbiome and host transcriptomes reveals associations between treatment outcomes and immunotherapy‐induced colitis	17
In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor	17
Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1	17
Targeting senescence as an anticancer therapy	17
EWI‐2 controls nucleocytoplasmic shuttling of EGFR signaling molecules and miRNA sorting in exosomes to inhibit prostate cancer cell metastasis	17
Immune modulation underpins the anti‐cancer activity of HDAC inhibitors	17
Overexpression of GLT1D1 induces immunosuppression through glycosylation of PD‐L1 and predicts poor prognosis in B‐cell lymphoma	17
Long non‐coding NR2F1‐AS1 is associated with tumor recurrence in estrogen receptor‐positive breast cancers	17
Secretogranin II impairs tumor growth and angiogenesis by promoting degradation of hypoxia‐inducible factor‐1α in colorectal cancer	17
TGF‐β‐induced IGFBP‐3 is a key paracrine factor from activated pericytes that promotes colorectal cancer cell migration and invasion	17
Role of radiation oncology in modern multidisciplinary cancer treatment	16
The KRAS/Lin28B axis maintains stemness of pancreatic cancer cells via the let‐7i/TET3 pathway	16
Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1‐driven acute lymphoblastic leukemia	16
Integrating bulk and single‐cell RNA sequencing reveals cellular heterogeneity and immune infiltration in hepatocellular carcinoma	16
KMT2C promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer	16
Metagenomic analysis of primary colorectal carcinomas and their metastases identifies potential microbial risk factors	16
Multiplex RNA‐based detection of clinically relevant MET alterations in advanced non‐small cell lung cancer	16
Benchmarking HLA genotyping and clarifying HLA impact on survival in tumor immunotherapy	16
Cancer‐associated fibroblasts promote tumor progression by lncRNA‐mediated RUNX2/GDF10 signaling in oral squamous cell carcinoma	16
Mitochondrial DNA mutations in ageing and cancer	16
HRD1 inhibits fatty acid oxidation and tumorigenesis by ubiquitinating CPT2 in triple‐negative breast cancer	16
Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression	16
The miR‐19b‐3p‐MAP2K3‐STAT3 feedback loop regulates cell proliferation and invasion in esophageal squamous cell carcinoma	16
Patient‐derived organoids as a preclinical platform for precision medicine in colorectal cancer	16
Neuronal Calcium Sensor 1 is up‐regulated in response to stress to promote cell survival and motility in cancer cells	16
Genome‐scale CRISPR screening identifies cell cycle and protein ubiquitination processes as druggable targets for erlotinib‐resistant lung cancer	15
Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non‐small‐cell lung cancer treated with pembrolizumab	15
Role of aneuploid circulating tumor cells and CD31+ circulating tumor endothelial cells in predicting and monitoring anti‐angiogenic therapy efficacy in advanced NSCLC	15
Neurotensin receptor 1 signaling promotes pancreatic cancer progression	15
Norepinephrine‐CREB1‐miR‐373 axis promotes progression of colon cancer	15
T2R bitter taste receptors regulate apoptosis and may be associated with survival in head and neck squamous cell carcinoma	15
Harnessing data science to advance radiation oncology	15
Mechanistic insights into p53‐regulated cytotoxicity of combined entinostat and irinotecan against colorectal cancer cells	15
DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies	15
Widespread overexpression from the four DNA hypermethylated HOX clusters in aggressive (IDHwt) glioma is associated with H3K27me3 depletion and alternative promoter usage	15
DNA repair as a shared hallmark in cancer and ageing	15
CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy	15
Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment	15
Therapeutic targeting with DABIL‐4 depletes myeloid suppressor cells in 4T1 triple‐negative breast cancer model	15
Identification and validation of novel DNA methylation markers for early diagnosis of lung adenocarcinoma	15
USP35 mitigates endoplasmic reticulum stress‐induced apoptosis by stabilizing RRBP1 in non‐small cell lung cancer	15
Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors	15
Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation	15
Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion	15
Cotargeting of miR‐126‐3p and miR‐221‐3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling	15
NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment	15
Effect of p53 and its N‐terminally truncated isoform, Δ40p53, on breast cancer migration and invasion	15
Discovery and validation of extracellular vesicle‐associated miRNAs as noninvasive detection biomarkers for early‐stage non‐small‐cell lung cancer	14
Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations	14
Acquired small cell lung cancer resistance to Chk1 inhibitors involves Wee1 up‐regulation	14
Concordance between TP53 alterations in blood and tissue: impact of time interval, biopsy site, cancer type and circulating tumor DNA burden	14
A small molecule targeting CHI3L1 inhibits lung metastasis by blocking IL‐13Rα2‐mediated JNK‐AP‐1 signals	14
Molecular genomic features associated with in vitro response of the NCI‐60 cancer cell line panel to natural products	14
The Sp1/FOXC1/HOTTIP/LATS2/YAP/β‐catenin cascade promotes malignant and metastatic progression of osteosarcoma	14
VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancer	14
ERK signaling controls productive HIF‐1 binding to chromatin and cancer cell adaptation to hypoxia through HIF‐1α interaction with NPM1	14
Mitochondrial STAT3 regulates antioxidant gene expression through complex I‐derived NAD in triple negative breast cancer	14
PD‐1‐induced T cell exhaustion is controlled by a Drp1‐dependent mechanism	14
imPlatelet classifier: image‐converted RNA biomarker profiles enable blood‐based cancer diagnostics	14
The RNA‐binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma	14
The MSP‐RON axis stimulates cancer cell growth in models of triple negative breast cancer	14
USP22‐mediated deubiquitination of PTEN inhibits pancreatic cancer progression by inducing p21 expression	14
SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A–c‐Myc axis	14
Tspan5 promotes epithelial–mesenchymal transition and tumour metastasis of hepatocellular carcinoma by activating Notch signalling	14
Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma	14
BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN	14
Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells	14
BMP9‐ID1 signaling promotes EpCAM‐positive cancer stem cell properties in hepatocellular carcinoma	14
The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel‐resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe	13
Pan‐cancer analysis reveals sex‐specific signatures in the tumor microenvironment	13
FGFR1 clustering with engineered tetravalent antibody improves the efficiency and modifies the mechanism of receptor internalization	13
Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population‐based testing program	13
Molecular characteristics and tumorigenicity of ascites‐derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer	13
Anti‐pyroptotic function of TGF‐β is suppressed by a synthetic dsRNA analogue in triple negative breast cancer cells	13
Genomic characterization of small cell carcinomas of the uterine cervix	13
Characterization of fragment sizes, copy number aberrations and 4‐mer end motifs in cell‐free DNA of hepatocellular carcinoma for enhanced liquid biopsy‐based cancer detection	13
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma	13
Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC	13
Detection of gene mutations and gene–gene fusions in circulating cell‐free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis	13
Novel CTRP8‐RXFP1‐JAK3‐STAT3 axis promotes Cdc42‐dependent actin remodeling for enhanced filopodia formation and motility in human glioblastoma cells	13